The Discounted Cash Flow (DCF) valuation of Boston Scientific Corp (BSX) is 63.22 USD. With the latest stock price at 100.72 USD, the upside of Boston Scientific Corp based on DCF is -37.2%.
Based on the latest price of 100.72 USD and our DCF valuation, Boston Scientific Corp (BSX) is a sell. selling BSX stocks now will result in a potential gain of 37.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.1% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 38.56 - 155.08 | 63.22 |
| Upside | -61.7% - 54.0% | -37.2% |